JACC:以运动为基础的心脏康复可降低心血管疾病死亡率

2016-01-05 崔倩 译 MedSci原创

虽然建议使用冠状动脉心脏疾病(CHD)的管理准则,但人们对于从运动锻炼为主的心脏康复(CR)现有的荟萃分析证据的适用性已经产生了质疑。

虽然建议使用冠状动脉心脏疾病(CHD)的管理准则,但人们对以运动锻炼为主的心脏康复(CR)现有的荟萃分析证据的适用性已产生了质疑。

这项研究的目的是更新对于CHD基于运动型CR的Cochrane系统评价和meta分析。

研究人员检索了直到2014年7月的Cochrane中心对照注册试验、医学文献、文摘、CINAHL、科学引文索引扩展。检索的论文、系统评价和试验注册都是手动检索。研究人员包括了至少6个月的随访的随机对照试验,这些比较了无运动CR无锻炼控制后心肌梗死或血管重建术,或心绞痛或冠心病的发生情况,并通过血管造影进行确定。两位作者筛选了标题,提取数据,并评估偏倚风险。研究人员采用随机效应荟萃分析进行汇总,分层分析通过检查潜在的治疗效果进行修饰。

该研究共包括63项研究,14486名参与者,中位随访时间为12个月。总体而言,CR降低了心血管死亡率(相对风险:0.74;95%置信区间:0.64至0.86)和住院的风险(相对风险:0.82;95%置信区间:0.70至0.96)。对总死亡率、心肌梗死或血管重建无显著效果。大多数研究(20项研究中的14项)显示:与对照参与者相比,基于运动的CR可提高寿命在1或多个结构域的健康质量。

这项研究证实,运动型心脏康复降低了心血管疾病的死亡率,并减少了住院率和提高了生活质量。这些好处似乎独立于研究质量、环境和发表日期,对于不同患者和干预类型是一致的。
原始出处:

Lindsey Anderson,Neil Oldridge,David R. Thompson,et al.Exercise-Based Cardiac Rehabilitation for Coronary Heart Disease,JACC,2016.1.5

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=292570, encodeId=89e52925e047, content=很不错哦.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Sat Mar 03 10:13:38 CST 2018, time=2018-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1853462, encodeId=6a3c1853462ec, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Wed Oct 19 00:57:00 CST 2016, time=2016-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56536, encodeId=79b65653648, content=不错,学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzTetibytbqFDmFITWHyBWbxU7S9MYibgPSqvu0sYteH0N6zXqbU0Kf3Mbdb7yWM1Kud3zPgYBibE2SZ/0, createdBy=da7696924, createdName=qingfengqishi5, createdTime=Wed Jan 13 07:45:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325159, encodeId=9cc7132515966, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Wed Jan 06 23:57:00 CST 2016, time=2016-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497948, encodeId=dfb7149e948be, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Wed Jan 06 23:57:00 CST 2016, time=2016-01-06, status=1, ipAttribution=)]
    2018-03-03 owlhealth

    很不错哦.学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=292570, encodeId=89e52925e047, content=很不错哦.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Sat Mar 03 10:13:38 CST 2018, time=2018-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1853462, encodeId=6a3c1853462ec, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Wed Oct 19 00:57:00 CST 2016, time=2016-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56536, encodeId=79b65653648, content=不错,学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzTetibytbqFDmFITWHyBWbxU7S9MYibgPSqvu0sYteH0N6zXqbU0Kf3Mbdb7yWM1Kud3zPgYBibE2SZ/0, createdBy=da7696924, createdName=qingfengqishi5, createdTime=Wed Jan 13 07:45:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325159, encodeId=9cc7132515966, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Wed Jan 06 23:57:00 CST 2016, time=2016-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497948, encodeId=dfb7149e948be, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Wed Jan 06 23:57:00 CST 2016, time=2016-01-06, status=1, ipAttribution=)]
    2016-10-19 hbwxf
  3. [GetPortalCommentsPageByObjectIdResponse(id=292570, encodeId=89e52925e047, content=很不错哦.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Sat Mar 03 10:13:38 CST 2018, time=2018-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1853462, encodeId=6a3c1853462ec, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Wed Oct 19 00:57:00 CST 2016, time=2016-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56536, encodeId=79b65653648, content=不错,学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzTetibytbqFDmFITWHyBWbxU7S9MYibgPSqvu0sYteH0N6zXqbU0Kf3Mbdb7yWM1Kud3zPgYBibE2SZ/0, createdBy=da7696924, createdName=qingfengqishi5, createdTime=Wed Jan 13 07:45:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325159, encodeId=9cc7132515966, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Wed Jan 06 23:57:00 CST 2016, time=2016-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497948, encodeId=dfb7149e948be, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Wed Jan 06 23:57:00 CST 2016, time=2016-01-06, status=1, ipAttribution=)]
    2016-01-13 qingfengqishi5

    不错,学习了!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=292570, encodeId=89e52925e047, content=很不错哦.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Sat Mar 03 10:13:38 CST 2018, time=2018-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1853462, encodeId=6a3c1853462ec, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Wed Oct 19 00:57:00 CST 2016, time=2016-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56536, encodeId=79b65653648, content=不错,学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzTetibytbqFDmFITWHyBWbxU7S9MYibgPSqvu0sYteH0N6zXqbU0Kf3Mbdb7yWM1Kud3zPgYBibE2SZ/0, createdBy=da7696924, createdName=qingfengqishi5, createdTime=Wed Jan 13 07:45:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325159, encodeId=9cc7132515966, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Wed Jan 06 23:57:00 CST 2016, time=2016-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497948, encodeId=dfb7149e948be, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Wed Jan 06 23:57:00 CST 2016, time=2016-01-06, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=292570, encodeId=89e52925e047, content=很不错哦.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3b2c1627329, createdName=owlhealth, createdTime=Sat Mar 03 10:13:38 CST 2018, time=2018-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1853462, encodeId=6a3c1853462ec, content=<a href='/topic/show?id=48351020537' target=_blank style='color:#2F92EE;'>#JACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10205, encryptionId=48351020537, topicName=JACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=55ce62, createdName=hbwxf, createdTime=Wed Oct 19 00:57:00 CST 2016, time=2016-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56536, encodeId=79b65653648, content=不错,学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzTetibytbqFDmFITWHyBWbxU7S9MYibgPSqvu0sYteH0N6zXqbU0Kf3Mbdb7yWM1Kud3zPgYBibE2SZ/0, createdBy=da7696924, createdName=qingfengqishi5, createdTime=Wed Jan 13 07:45:00 CST 2016, time=2016-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1325159, encodeId=9cc7132515966, content=<a href='/topic/show?id=96c71804b7' target=_blank style='color:#2F92EE;'>#ACC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1804, encryptionId=96c71804b7, topicName=ACC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e452500029, createdName=12498568m50暂无昵称, createdTime=Wed Jan 06 23:57:00 CST 2016, time=2016-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497948, encodeId=dfb7149e948be, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Wed Jan 06 23:57:00 CST 2016, time=2016-01-06, status=1, ipAttribution=)]

相关资讯

《疯狂的石头》片尾曲主唱踢球时猝死,年仅36岁!(附运动性猝死防治)

据重庆晨报报道,著名音乐人李润,曾演唱过电影《疯狂的石头》片尾曲《我是重庆崽儿》的重庆本土歌手李润因踢球引发心脏病抢救无效去世,年仅36岁!重庆崽儿,一路走好! 看到这则消息,不禁让人扼腕痛惜,近些年来,“猝死”事件反复出现让人扼腕痛惜,据统计,绝大多数病人根本来不及去医院,救护车也不可能在几分钟内到达病人身边,病人便在发病现场或送往医院途中发生猝死。因此,掌握现场CPR技能的意义是不言而喻

Int J Sport Nutr Exerc Metab:咖啡因还能提高运动耐力!!!

近日,来自于佐治亚大学的研究人员在国际运动营养学与新陈代谢杂志期刊上发表了一项回顾性研究成果,这项研究的成果表明在运动前喝咖啡有可能提高运动员的耐力。该研究的主导者Simon Higgins教授,为了探讨咖啡中的咖啡因与个人体能耐力之间的相互关系,进行了600项运动试验。在过去,人们通常认为咖啡因仅是一种常用的兴奋剂和精神药物。据不完全统计的数据表明,美国人平均每天消耗27.3盎咖啡。另外平均每天

大快朵颐后,你的运动量够吗?

最新公布的一组信息图表显示了你在快餐店大快朵颐之后要在健身房里流多少汗才能消耗这些能量。 在食用炸鸡,比萨和汉堡后,人们需要在健身房里进行超过一个小时的有氧运动或者举铁,然而女性还要比男性付出更多的努力才能消耗这些餐中的卡路里。 消化一个麦当劳的巨无霸,男人需要做42分钟有氧和57分钟举铁。这种著名的三加二汉堡含有490卡路里的热量,女人则要比男人多运动至少一个小时才能消耗掉。一个

NEJM:单硝酸异山梨酯对射血分数正常心力衰竭患者的影响

背景硝酸酯类药物可增强射血分数正常性心力衰竭患者的心脏功能。该研究的目的是比较单硝酸异山梨酯或安慰剂的效果对这类患者日常活动的影响。 方法 在这个多中心、双盲、交叉的研究中,110名射血分数正常性心力衰竭患者被随机分配至实验组(6周内逐渐递增单硝酸异山梨酯的剂量,由30mg/d至60mg/d,最终为120mg/d)或安慰剂,之后再交叉入另一组6周。研究关注的主要结果是患者的日常活动水平,以120m

plos med:“睡得多+坐的久+运动少”等于超过4倍英年早逝风险!

“夜间睡觉超过9小时+白天久坐”是一个非常危险的组合模式,尤其是在缺乏锻炼的日子。有研究表明,一个人睡的太多+坐的太久(超过7小时)+运动太少(<150分钟/周),比没有这些不健康生活习惯的人群,英年早逝的风险高4倍!作者Melody Ding说:“近年来越来越多的证据表面,久坐有害身体健康;关于睡眠对健康的影响研究也越来越多;而我们的研究将两者结合;如果再加上缺乏锻炼,则是三重打击。研究表明我们

J Clin Endocrinol Metab:运动加上健康的饮食可提高PCOS女性的生育能力

据发表于Journal of Clinical Endocrinology & Metabolism的一项新的研究表明,激素异常的多囊卵巢综合症(PCOS)女性或可通过减肥和锻炼来提高自身的生育能力。